Kane Biotech 股份在周五高额交易中猛涨28.6%, Kane Biotech shares surged 28.6% on Friday amid heavy trading, with no official reason given.

Kane Biotech (CVE:KNE) 股份在星期五上升了28.6%至0.05科多巴元,交易量猛增150万股,比平均数高出38%,但没有提供举行集会的具体理由。 Kane Biotech (CVE:KNE) shares jumped 28.6% to C$0.05 on Friday, with trading volume surging to 1.5 million shares—380% above average—though no specific reason for the rally was provided. 加拿大生物技术公司的重点是生物胶卷的预防和清除、销售诸如Revyve伤口凝胶和DermaKB皮肤护理物品等产品。 The Canadian biotech firm, focused on biofilm prevention and removal, markets products like Revyve wound gel and DermaKB skincare items. 股票市场上限为753万科多巴元,P/E比率为负值,流动性比率低于1,50天和200天移动平均数均为0.04科多巴元。 The stock has a market cap of C$7.53 million, a negative P/E ratio, and liquidity ratios below 1, with 50-day and 200-day moving averages both at C$0.04.